Literature DB >> 8622000

Comparing period prevalences with application to drug utilization.

B H McFarland1.   

Abstract

Period prevalence is frequently measured in studies based on administrative data such as that from health maintenance organizations. For example, treated prevalence and drug utilization prevalence are important measures that are typically defined in relationship to a specified time period. Often one wishes to compare administrative data with period prevalences based on national surveys. It may also be of interest to compare period prevalences from two (or more) different data sources. This comparison is not straightforward owing to the problem of "person-time at risk." This article reviews the values and drawbacks of period prevalence as compared with cumulative incidence. L ife table methodology is described for comparing period prevalence data from administrative databases with survey results. This technique can be extended to the comparison of period prevalence observations from two or more administrative data bases. Examples are given pertaining to hypnotic drug use and the treatment of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8622000     DOI: 10.1016/0895-4356(95)00573-0

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  3 in total

1.  Organization and financing of alcohol and substance abuse programs for American Indians and Alaska Natives.

Authors:  Bentson H McFarland; Roy M Gabriel; Douglas A Bigelow; R Dale Walker
Journal:  Am J Public Health       Date:  2006-06-29       Impact factor: 9.308

2.  Resource utilization associated with irritable bowel syndrome in the United States 1987-1997.

Authors:  Ya-Chen Tina Shih; Victoria E Barghout; Robert S Sandler; Priti Jhingran; Medha Sasane; Suzanne Cook; David C Gibbons; Michael Halpern
Journal:  Dig Dis Sci       Date:  2002-08       Impact factor: 3.199

3.  A pharmacovigilance study in medicine department of tertiary care hospital in chhattisgarh (jagdalpur), India.

Authors:  H Singh; N Dulhani; Bn Kumar; P Singh; P Tewari; K Nayak
Journal:  J Young Pharm       Date:  2010-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.